PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy.\', \'Department of Hematology/Oncology, University of Chicago Medicine, Chicago, Illinois, USA.\', \'Division of Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.\', \'Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.\', \'David Geffen School of Medicine, UCLA, University of California Los Angeles, Los Angeles, California, USA.\', \'Department of Oncology, Centre Hospitalier Universitaire Vaudois, CHUV, Lausanne, Switzerland solange.peters@chuv.ch.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00226610.1136/jitc-2020-002266
?:doi
?:hasPublicationType
?:journal
  • Journal for immunotherapy of cancer
is ?:pmid of
?:pmid
?:pmid
  • 33737345
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.798
?:rankingScore_hIndex
  • 26
?:title
  • Severity of COVID-19 in patients with lung cancer: evidence and challenges.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33737345>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33737345>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all